How Effective Are Supplementary Doses of Opioids for Dyspnea in Terminally Ill Cancer Patients? A Randomized Continuous Sequential Clinical Trial
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 17 (4), 256-265
- https://doi.org/10.1016/s0885-3924(98)00157-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Subcutaneous Morphine for Dyspnea in Cancer PatientsAnnals of Internal Medicine, 1993
- Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patientsThe Lancet, 1993
- Effects of morphine on the dyspnea of terminal cancer patientsJournal of Pain and Symptom Management, 1990
- Long-term management of respiratory symptoms in advanced cancerJournal of Pain and Symptom Management, 1990
- Dyspnea Management: “To Take into the Air my Quiet Breath” (2)Journal of Palliative Care, 1989
- An approach to dyspnea in cancer patientsJournal of Pain and Symptom Management, 1989
- Dyspnea in Terminally Ill Cancer PatientsChest, 1986
- OPIOID PEPTIDE INTERACTIONS WITH RESPIRATORY AND CIRCULATORY SYSTEMSBritish Medical Bulletin, 1983
- Accuracy of subjective measurements made with or without previous scores: an important source of error in serial measurement of subjective states.Annals Of The Rheumatic Diseases, 1979
- Diminished Ventilatory Response to Hypoxia and Hypercapnia after Morphine in Normal ManNew England Journal of Medicine, 1975